QuickView for Muscarinic acetylcholine receptor M4 (biogroup)

1. Drug target sets for approved compounds
2. Leukocytes from Down syndrome patients with early dementia marked by cognitive disability
3. Skin biopsies (lesional and non-lesional) from patients with atopic dermatitis or psoriasis
4. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
5. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)

There were no matches for Muscarinic acetylcholine receptor M4

1. PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing
2. Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release …
3. Rate of Postoperative Delirium and Postoperative Cognitive Dysfunction After Spinal Anesthesia
4. Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
5. Analysis of Frailty Syndrome Within the Framework of the Innovation Fund Project PRÄP-GO (ANA-PRÄP-G…